TE
RLAY icon

Tema ETFs’s Relay Therapeutics RLAY Stock Holding History

Tema ETFs’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.31M Buy
176,782
+22,682
+15% +$329K 0.11% 139
2026
Q1 		$1.53M Buy
154,100
+42,545
+38% +$381K 0.1% 180
2025
Q4 		$944K Buy
111,555
+18,090
+19% +$129K 0.07% 251
2025
Q3 		$488K Sell
93,465
-3,685
-4% -$14.1K 0.04% 385
2025
Q2 		$336K Buy
97,150
+8,040
+9% +$23.9K 0.09% 149
2025
Q1 		$233K Buy
89,110
+24,455
+38% +$95.8K 0.07% 137
2024
Q4 		$266K Buy
+64,655
New +$352K 0.11% 134

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Tema ETFs's RLAY Position: Q2 2026 in Review

Tema ETFs increased its Relay Therapeutics (RLAY) stake by 15% in Q2 2026, buying an estimated $329K and bringing the position to 176,782 shares worth $3.31M. The position accounts for 0.11% of the portfolio, ranked #139.

Tema ETFs first reported a position in RLAY in Q4 2024 and has held it in 7 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Tema ETFs held 176,782 shares of Relay Therapeutics worth $3.31M as of Q2 2026.
  • Tema ETFs bought 22,682 Relay Therapeutics shares in Q2 2026, an estimated $329K.
  • Relay Therapeutics made up 0.11% of Tema ETFs's portfolio in Q2 2026, its #139 holding.
  • Tema ETFs first reported a position in Relay Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.